Mida tähendab "Tühjenda"?
Loom ei kanna mutatsiooni. See ei arenda haigust ja ei anna seda edasi.
Cerebellar Hypoplasia (CHP) in White Swiss Shepherd Dogs is a genetic condition affecting coordination and balance. Early DNA testing for CHP helps breeders identify carriers and prevent passing this neurological disorder to puppies. Accurate CHP DNA tests ensure healthier litters and improve the overall well-being of White Swiss Shepherds. Understanding the genetic risks through testing supports responsible breeding practices. If you own a White Swiss Shepherd, consider CHP DNA testing to safeguard your dog's health. Reliable CHP testing services are available from specialized veterinary genetics labs. Protect your dog’s future with early detection and informed breeding decisions.
Cerebellar Hypoplasia (CHP) in White Swiss Shepherd Dogs is a genetic condition affecting the development of the cerebellum, leading to coordination and balance issues. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing helps manage the condition and reduce its prevalence in the breed. Responsible breeding practices rely on such genetic screening to maintain healthy bloodlines. Overall, the DNA test is a valuable tool for protecting the health of White Swiss Shepherd Dogs.
See DNA test on kaasas alates meie pakist Basic — ja on ka osa pakkidest Basic, Standard, Advanced, Complete.
Vaadake DNA testipakette →Cerebellar Hypoplasia (CHP) is a neurological condition affecting the development of the cerebellum, a part of the brain responsible for coordination and balance. In White Swiss Shepherd Dogs, this condition can lead to a range of motor skill challenges due to the underdevelopment of the cerebellum. Affected dogs may exhibit symptoms such as uncoordinated movement, difficulty walking, and tremors, which can significantly impact their quality of life.
The condition is believed to have a hereditary component, and it is caused by genetic mutations that interfere with normal brain development. Identifying these mutations through DNA testing can help breeders make informed decisions and reduce the prevalence of CHP in future generations. Understanding the genetic basis of this condition is crucial for managing and breeding practices, as it allows for the identification of carriers and affected individuals.
Dogs with Cerebellar Hypoplasia may display a variety of clinical signs that can vary in severity. Common symptoms include difficulty with balance, an unsteady gait, and abnormal head movements. Some dogs may also exhibit signs of anxiety or stress due to their inability to coordinate movements effectively. These symptoms often become apparent at a young age, and while the condition is not progressive, it requires careful management to ensure the well-being of the affected dog.
Diagnosis of CHP typically involves a combination of clinical evaluation and genetic testing. Veterinarians may assess the dog’s physical condition and observe its motor skills to identify potential neurological issues. Genetic testing can confirm the presence of mutations associated with the condition, providing a clearer understanding of the dog's health status and potential risks for breeding.
While there is currently no cure for Cerebellar Hypoplasia, affected dogs can lead fulfilling lives with appropriate management strategies. Owners should focus on creating a safe environment that minimizes the risk of injury due to mobility challenges. Regular veterinary check-ups, tailored exercise programs, and supportive care can help enhance the quality of life for dogs with CHP. Additionally, engaging in positive reinforcement training can assist in building confidence and improving coordination.
Cerebellar Hypoplasia in White Swiss Shepherd Dogs is a condition that requires attention from breeders, veterinarians, and dog owners alike. By understanding the genetic underpinnings and clinical implications of CHP, stakeholders can work towards responsible breeding practices and improved care for affected dogs. Awareness and education are key in ensuring that these dogs receive the support they need to thrive.
Loom ei kanna mutatsiooni. See ei arenda haigust ja ei anna seda edasi.
Ei. Loom on üldiselt terve, kuid võib mutatsiooni omale edasi anda järglased.
Sellel on kaks muteerunud koopiat. Sõltuvalt sellest on oodata kliinilisi tunnuseid haigus. Seda ei tohiks aretada.
Mõned haigused on sooga seotud, mistõttu nende väljendus varieerub sõltuvalt looma sugu.
This DNA test detects the mutation associated with Cerebellar Hypoplasia In White Swiss Shepherd Dog (CHP-WSS) in order to identify clear, carrier, or at-risk animals.
DNA testimine aitab kasvatajatel planeerida turvalisemaid paaritusi ja vähendada mutatsiooni järglastele edasikandumise ohtu.
Selle testi jaoks teatatud pärimisrežiim on autosoomne retsessiivne.
This test analyses the mutation RELN c.2839del.
Mitte tingimata. Tõlgendamine sõltub pärimismustrist ja sellest tulenevast genotüübist.
Littlejohn Mathew D, Sneddon Nick, Dittmer Keren, Keehan Mike, Stephen Melissa, Drögemüller Michaela, Garrick Dorian. A frameshift-deletion mutation in Reelin causes cerebellar hypoplasia in White Swiss Shepherd dogs. Anim Genet. 2023 Oct;54(5):632-636. doi: 10.1111/age.13336. Epub 2023 Jun 19.
Teie privaatsus, teie valik
Kasutame veebisaidi käitamiseks olulisi küpsiseid. Valikulised küpsised (nt manustatud sisu pakkujad) on vaikimisi keelatud ja lubatud ainult siis, kui nõustute. Saate oma valikut igal ajal muuta, kasutades nuppu "Küpsised".
Nõutav põhifunktsioonide ja turvalisuse jaoks. Alati lubatud.
Parandab selliseid funktsioone nagu eelistuste salvestamine või mittereklaamivad manused.
Aitab meil mõista saidi kasutamist. Vaikimisi keelatud.
Reklaamimine/jälgimine saitidel (mõned video/kaardi manused). Vaikimisi keelatud.